These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 497437)

  • 21. QSARS of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals.
    Benigni R; Richard AM
    Mutat Res; 1996 Nov; 371(1-2):29-46. PubMed ID: 8950348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. History, present and future, of heterocyclic amines, cooked food mutagens.
    Sugimura T
    Princess Takamatsu Symp; 1995; 23():214-31. PubMed ID: 8844813
    [No Abstract]   [Full Text] [Related]  

  • 23. The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk.
    Weisburger JH; Williams GM
    Toxicol Sci; 2000 Sep; 57(1):4-5. PubMed ID: 10966505
    [No Abstract]   [Full Text] [Related]  

  • 24. The parallelogram approach in studies of genotoxic effects.
    Anderson D; Sorsa M; Waters MD
    Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclopenta-polycyclic aromatic hydrocarbons: potential carcinogens and mutagens.
    Fu PP; Beland FA; Yang SK
    Carcinogenesis; 1980 Aug; 1(8):725-7. PubMed ID: 11272127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special issue on food borne botanical genotoxic carcinogens.
    Rietjens IMCM
    Food Chem Toxicol; 2018 Oct; 120():708. PubMed ID: 30171971
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals.
    Gold LS; Slone TH; Stern BR; Bernstein L
    Mutat Res; 1993 Mar; 286(1):75-100. PubMed ID: 7678909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutagens and carcinogens in cooked foods: concentration, potency, and risk.
    Felton JS; Knize MK; Turteltaub KW; Buonarati MH; Taylor RT; Vanderlaan M; Watkins BE; Tucker JD; Thompson LH
    Adv Exp Med Biol; 1991; 289():133. PubMed ID: 1897388
    [No Abstract]   [Full Text] [Related]  

  • 29. Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.
    Doktorova TY; Yildirimman R; Vinken M; Vilardell M; Vanhaecke T; Gmuender H; Bort R; Brolen G; Holmgren G; Li R; Chesne C; van Delft J; Kleinjans J; Castell J; Bjorquist P; Herwig R; Rogiers V
    Carcinogenesis; 2013 Jun; 34(6):1393-402. PubMed ID: 23393228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of food-associated polycyclic aromatic hydrocarbon carcinogens.
    Dipple A; Bigger CA
    Mutat Res; 1991; 259(3-4):263-76. PubMed ID: 2017212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying Potential Breast Carcinogens: A New Approach.
    Nicole W
    Environ Health Perspect; 2015 Dec; 123(12):A305. PubMed ID: 26623998
    [No Abstract]   [Full Text] [Related]  

  • 32. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

  • 33. The clastogenicity of chemicals in cultured mammalian cells.
    Ishidate M; Harnois MC
    Mutagenesis; 1987 May; 2(3):240-3. PubMed ID: 3325752
    [No Abstract]   [Full Text] [Related]  

  • 34. Gender-related differences in response to mutagens and carcinogens.
    Kirsch-Volders M; Bonassi S; Herceg Z; Hirvonen A; Möller L; Phillips DH
    Mutagenesis; 2010 May; 25(3):213-21. PubMed ID: 20194421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Toxicity study for acrylamide].
    Han JY; Zhang CW
    Wei Sheng Yan Jiu; 2006 Jul; 35(4):513-5. PubMed ID: 16986535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are carcinogens direct mutagens?
    Lopez-Bigas N; Gonzalez-Perez A
    Nat Genet; 2020 Nov; 52(11):1137-1138. PubMed ID: 33128047
    [No Abstract]   [Full Text] [Related]  

  • 37. Utilization of alternative species for toxicity testing: an overview.
    Goss LB; Sabourin TD
    J Appl Toxicol; 1985 Aug; 5(4):193-219. PubMed ID: 3900184
    [No Abstract]   [Full Text] [Related]  

  • 38. Carcinogenicity of 1,3-butadiene.
    Melnick RL; Huff J; Matanoski GM
    Lancet; 1992 Sep; 340(8821):724-5. PubMed ID: 1355815
    [No Abstract]   [Full Text] [Related]  

  • 39. A cytological test system to detect mutagen-induced DNA single-strand breaks: posttreatment of G2 phase CHO cells with Neurospora endonuclease.
    Nowak C; Obe G; van Kesteren-van Leeuwen AC; Natarajan AT
    Mutat Res; 1984; 140(2-3):111-5. PubMed ID: 6205262
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.